Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Initial NICE recommendations for Glivec rebutted by Novartis

May 26, 2004

Additional analysis of response data from phase III Dacogen study in MDS

May 26, 2004

Acceptance of Onco TCS NDA triggers payment to Elan

May 26, 2004

Novel CDK2/cyclin A inhibitor effective antitumor agent in vivo

May 26, 2004

Enrollment under way in phase I study of NQO2 anticancer therapy

May 26, 2004

inGenium aids Peregrine's development of monoclonal antibody for lymphoma

May 25, 2004

Onco TCS NDA accepted for review

May 25, 2004

FDA approves Taxotere for treatment of prostate cancer

May 25, 2004

Two series of tyrosine kinase inhibitors described by BMS researchers

May 24, 2004

New CDK inhibitors for cancer and other disorders under study at Sanofi-Synthelabo

May 24, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...